Please ensure Javascript is enabled for purposes of website accessibility

Securities

Mar 10, 2025

Securities – Fraud – Scienter

Where plaintiffs have moved for leave to file a proposed second amended complaint, that motion should be allowed in part, as the plaintiffs present allegations that provide a strong inference of scienter only as to statements identified as Nos. 7, 13(a), 13(b) and 14(a).

Securities and Exchange Commission
Feb 19, 2025

Penny stock trader liable for selling unregistered securities

A Connecticut attorney who churned the issuance of $2,000 in penny stocks in a new business that operated an unprofitable yoga studio into nearly $700,000 in profit two years later could be liable for selling unregistered securities in violation of federal law, the 1st U.S. Circuit Court of Appeals has determined.

Feb 18, 2025

Securities – Unregistered sales

Where the Securities and Exchange Commission brought a civil enforcement action, the lower court did not err by awarding the SEC partial summary judgment but did err in imposing equitable remedies and in concluding that it lacked the power to issue a civil penalty.

Feb 11, 2025

Securities – Fraud – Merger

Where a securities fraud complaint has been filed, the complaint should be dismissed with prejudice based on insufficient allegations of falsity and scienter.

Jan 29, 2025

Securities – Fraud

Where the Securities and Exchange Commission has brought several claims of securities fraud, the SEC has not met its burden of proving by a preponderance of the evidence that two defendants violated Section 17(a)(1) of the Securities Act or Section 10(b) of the Exchange Act.

Nov 6, 2024

Securities – Scienter – Confidential witnesses

Where (1) a securities fraud complaint was dismissed with prejudice, (2) the dismissal was affirmed on appeal, and (3) the lead plaintiff has filed a motion to vacate, claiming that newly discovered evidence cures the deficiencies that warranted dismissal, the motion was untimely and lacks merit, so it must be denied.

Nov 4, 2024

Securities – Interlocutory appeal

Where (1) a defendant’s motion to dismiss federal claims was denied, (2) the defendant’s motion for leave to seek an interlocutory appeal was allowed, and (3) the plaintiff has moved to amend its complaint, the plaintiff’s motion to amend should be denied without prejudice, as allowing that motion would delay the defendant’s pursuit of an interlocutory appeal and thus would not serve the i[...]

Oct 30, 2024

Securities – Offeror status – MUSA

Where a complaint has been filed including a count alleging a violation of the Massachusetts Uniform Securities Act, that count must be dismissed because the allegations only establish that the defendants may have caused a sale of securities by a third party, so they cannot be liable as offerors, nor can the defendants be liable as agents who materially aided in the sale of securities.

Oct 30, 2024

Securities – Fraud – ‘Scheme liability’ claim

Where a securities fraud complaint was dismissed, that decision should be affirmed because the lower court correctly determined that the complaint failed to plead any materially false or misleading statement or omission, while the plaintiff did not preserve a separate “scheme liability” claim.

Moakley U.S. Courthouse, Boston
Oct 30, 2024

Verdict in securities fraud case vacated over evidentiary ruling

The 1st U.S. Circuit Court of Appeals has ruled that the defendant in a securities fraud case should have been permitted to impeach the credibility of the plaintiff by cross-examining him about conduct that led a state medical board to determine that he misrepresented his credentials.

Oct 28, 2024

Securities – Cross-examination – Truthfulness

Where a plaintiff brought suit under the Massachusetts Uniform Securities Act, a jury verdict in favor of the plaintiff must be vacated in part, as it was an abuse of discretion for the trial court to preclude cross-examination about the facts underlying the Rhode Island medical board’s 2013 conclusion that the plaintiff had repeatedly misrepresented his medical credentials in a way that was int[...]

Sep 25, 2024

Securities – Class action – Appointment of lead plaintiff

Where a federal securities class action has been brought, a plaintiff claiming to have suffered a loss of $675,707.12 should be appointed as lead plaintiff.

Verdicts & Settlements

See All Verdicts & Settlements

Opinion Digests

See All Digests